ICMR partners with Zydus Lifesciences for Desidustat phase-2 trials in sickle cell disease patients, aiming for innovative ...

Zydus Lifesciences shares were trading flat on October 18 after the company received final approval to manufacture ...

The Delhi High Court division bench has allowed Zydus Lifesciences to sell its breast cancer drug Sigrima amidst accusations ...

Zydus Lifesciences Ltd on Thursday said it has received final approval from the US health regulator to manufacture its ...

On Sept. 13, Zydus Lifesciences signed a pact with US-based Viwit Pharmaceuticals for two MRI injectables and contrast agents. The pact has been inked for gadobutrol injection, a generic version of ...

Zydus Lifesciences received the FDA go-ahead to manufacture paliperidone extended-release tablets, 1.5 mg, 3 mg, 6 mg, and 9 ...

Zydus Lifesciences has received USFDA approval to manufacture generic Paliperidone extended-release tablets, used to treat ...

Zydus Lifesciences announced that it has received final approval from the United States Food and Drug Administration (USFDA) to manufacture Fludrocortisone Acetate tablets USP, 0.1 mg.

Zydus Lifesciences has received the USFDA's final approval to produce a generic version of Paliperidone extended-release ...

According to a regulatory filing by Zydus Lifesciences, the USFDA approved Paliperidone extended-release tablets.